Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

efavirenz-emtricitabine-tenofovir disoproxil fumarate

efavirenz-emtricitabine-tenofovir disoproxil fumarate
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Atripla TABLET, ORAL 600 mg-200 mg-300 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

efavirenz-emtricitabine-tenofovir disoproxil fumarate(Atripla)                                                                                          

  • 600 mg-200 mg-300 mg tablet oral once Daily

efavirenz (Sustiva) AND emtricitabine (Emtriva) AND tenofovir disoproxil fumarate (Viread)

  • THREE 200 mg capsules efavirenz PLUS ONE 200 mg capsule emtricitabine PLUS ONE 300 mg tablet tenofovir disoproxil fumarate once Daily

Atripla is non-formulary, not stocked, do not order. If an order is written, dispense each component drug separately.

Reviewed: September 26, 2006

Last updated: Dec. 20, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved